Scott D Solomon Selected Research

Spironolactone (Aldactone)

4/2022	Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT.
1/2022	Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT.
1/2022	Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries.
1/2021	Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
12/2020	Associations Between Depressive Symptoms and HFpEF-Related Outcomes.
12/2020	Estimating the Lifetime Benefits of Treatments for Heart Failure.
1/2020	Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository Study.
1/2020	Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT.
1/2020	Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trials.
12/2019	Influence of Age on Efficacy and Safety of Spironolactone in Heart Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott D Solomon Research Topics

Disease

429	Heart Failure 11/2022 - 11/2003
74	Myocardial Infarction 04/2022 - 12/2002
40	Type 2 Diabetes Mellitus (MODY) 11/2022 - 03/2005
38	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 09/2004
38	Chronic Renal Insufficiency 11/2022 - 12/2004
31	Stroke (Strokes) 01/2020 - 09/2004
28	Cardiomyopathies (Cardiomyopathy) 01/2022 - 07/2014
27	Atherosclerosis 01/2022 - 09/2011
26	Hypertension (High Blood Pressure) 01/2022 - 08/2006
25	Left Ventricular Dysfunction 06/2016 - 11/2003
24	Atrial Fibrillation 04/2022 - 10/2006
20	Hypotension (Low Blood Pressure) 10/2022 - 11/2003
19	Hyperkalemia 01/2022 - 10/2004
19	Bundle-Branch Block (Fascicular Block) 08/2021 - 06/2012
19	Diabetes Mellitus 01/2021 - 07/2004
18	Anemia 01/2019 - 01/2005
16	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 05/2009
14	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 05/2009
14	Heart Arrest (Cardiac Arrest) 01/2022 - 09/2004
12	Heart Diseases (Heart Disease) 01/2022 - 10/2013
11	COVID-19 11/2022 - 01/2020
11	Sudden Death 01/2022 - 10/2004
10	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 03/2009
10	Coronary Disease (Coronary Heart Disease) 01/2020 - 07/2006
9	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2021 - 08/2006
9	Ventricular Tachycardia 01/2017 - 12/2008
8	Fibrosis (Cirrhosis) 01/2022 - 06/2007
8	Respiratory Sounds (Crackle) 01/2021 - 12/2007
7	Kidney Diseases (Kidney Disease) 11/2022 - 01/2011
7	Human Influenza (Influenza) 04/2022 - 02/2016
7	Inflammation (Inflammations) 12/2021 - 07/2005
7	Albuminuria 11/2018 - 12/2007
6	Acute Coronary Syndrome 01/2022 - 05/2015
6	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2021 - 05/2017
6	Ventricular Remodeling 01/2021 - 05/2004
6	Systolic Heart Failure 01/2021 - 03/2013
6	Ventricular Fibrillation 09/2015 - 12/2008
5	Amyloidosis 01/2022 - 05/2014
5	Disease Progression 10/2021 - 01/2015
5	Neoplasms (Cancer) 08/2021 - 03/2005
5	Ischemic Stroke 01/2021 - 01/2016
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 07/2005

Drug/Important Bio-Agent (IBA)

95	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 10/2012
63	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 05/2008
57	Valsartan (Vals)FDA Link 01/2022 - 11/2003
55	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 10/2004
55	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 10/2012
51	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 11/2003
46	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021 - 08/2006
45	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 09/2011
39	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2011
39	dapagliflozinIBA 08/2022 - 01/2019
38	Enalapril FDA LinkGeneric 01/2022 - 08/2005
36	Natriuretic PeptidesIBA 01/2022 - 10/2013
34	candesartanIBA 10/2022 - 10/2004
31	Spironolactone (Aldactone)FDA LinkGeneric 04/2022 - 11/2007
31	CreatinineIBA 01/2022 - 09/2004
29	aliskiren FDA Link 08/2021 - 05/2008
28	Angiotensin Receptor AntagonistsIBA 01/2022 - 10/2004
24	paragonIBA 01/2022 - 01/2017
23	Darbepoetin alfa (Aranesp)FDA Link 01/2019 - 03/2005
21	Troponin T (Troponin T1)IBA 10/2022 - 09/2011
21	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 11/2003
17	Pharmaceutical PreparationsIBA 10/2022 - 05/2004
16	Hemoglobins (Hemoglobin)IBA 01/2019 - 02/2006
15	SodiumIBA 11/2022 - 12/2017
15	DiureticsIBA 04/2022 - 07/2010
13	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 12/2017
12	AngiotensinsIBA 01/2022 - 02/2008
12	Renin InhibitorsIBA 01/2018 - 05/2008
10	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 08/2006
10	TroponinIBA 01/2021 - 07/2005
9	omecamtiv mecarbilIBA 05/2022 - 11/2020
9	Cardiac MyosinsIBA 01/2022 - 01/2020
9	Prealbumin (Transthyretin)IBA 01/2021 - 05/2014
9	PotassiumIBA 01/2021 - 11/2007
8	Insulin (Novolin)FDA Link 10/2022 - 09/2004
8	AlbuminsIBA 10/2022 - 05/2009
8	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2022 - 02/2016
8	ReninIBA 01/2022 - 03/2005
8	Trinitrotoluene (TNT)IBA 01/2021 - 11/2011
7	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 01/2019
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2014
7	AldosteroneIBA 01/2022 - 11/2003
7	Sodium-Glucose Transport ProteinsIBA 11/2021 - 11/2019
7	Irbesartan FDA LinkGeneric 08/2021 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2005
6	Troponin IIBA 01/2021 - 07/2005
6	Captopril (Capoten)FDA LinkGeneric 06/2016 - 11/2003
5	lixisenatideIBA 01/2022 - 05/2015
5	SymportersIBA 10/2021 - 10/2018
5	Soluble Guanylyl CyclaseIBA 10/2020 - 12/2015
5	vericiguatIBA 10/2020 - 12/2015
5	C-Reactive ProteinIBA 01/2019 - 09/2011

Therapy/Procedure

151	Therapeutics 11/2022 - 02/2003
40	Cardiac Resynchronization Therapy 01/2022 - 10/2006
25	Defibrillators (Defibrillator) 01/2022 - 06/2011
13	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 08/2010
5	Resuscitation 01/2021 - 09/2004
5	Transplantation 01/2020 - 11/2012